하이퍼코퍼레이션
Financials
Valuation Metrics
하이퍼코퍼레이션's Market Cap is ₩160B. At end of 2025 it was ₩439B. Ranked #2352 of 2,410 in KR market (top 98%), #1584 of 1,631 on KOSDAQ (top 97%), #237 of 243 in Technology Hardware & Equipment (top 98%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 15.98B KRW | KR#2,352/2,410 Sec#237/243 |
| Revenue | 84.86B KRW | KR#1,514/2,410 Sec#145/243 |
| Net Income | -11.16B KRW | KR—/2,410 Sec—/243 |
| Total Assets | 51.72B KRW | KR#2,188/2,410 Sec#225/243 |
| Net Assets | 24.21B KRW | KR#2,233/2,410 Sec#225/243 |
| Employees | 94 | KR#1,680/2,410 Sec#156/243 |
| Value | ||
| P/B | 0.66x | KR#1,167/2,410 Sec#110/243 |
| P/S | 0.19x | KR#397/2,410 Sec#39/243 |
| FCF Yield | -52.02% | KR—/2,410 Sec—/243 |
| Profitability | ||
| ROE | -46.10% | KR#2,258/2,410 Sec#230/243 |
| ROA | -21.58% | KR#2,246/2,410 Sec#231/243 |
| Op. Margin | -5.91% | KR#1,882/2,410 Sec#183/243 |
| Revenue Growth | 30.67% | KR#380/2,410 Sec#51/243 |
| Financial Health | ||
| Debt Ratio | 113.63% | KR#1,653/2,410 Sec#176/243 |
| Total Debt | 14.95B KRW | KR#1,495/2,410 Sec#148/243 |
| FCF | -8.31B KRW | KR#1,647/2,410 Sec#161/243 |
| Cash | 3.83B KRW | KR#2,100/2,410 Sec#214/243 |
| Current Ratio | 1.13x | KR#1,569/2,410 Sec#175/243 |
| Performance | ||
| 1Y Return | -73.16% | KR#2,291/2,410 Sec#232/243 |
| 1M Return | 9.20% | KR#171/2,410 Sec#12/243 |
| From 52W High | -76.56% | KR#2,245/2,410 Sec#226/243 |
| 1Y MDD | -78.30% | KR#2,246/2,410 Sec#223/243 |
| Trading | ||
| Volume | 45,981 shares | KR#756/2,410 Sec#82/243 |
| Trading Value | 65.7M KRW | KR#1,427/2,410 Sec#145/243 |
| Foreign Own. | 0.00% | KR—/2,410 Sec—/243 |
| Per Share | ||
| EPS | -1,020 KRW | KR—/2,410 Sec—/243 |
| BPS | 2,212 KRW | KR#2,032/2,410 Sec#203/243 |
Company Info
Hyper Corporation, established in 1997 and headquartered in Gangnam-gu, Seoul, was listed on KOSDAQ in 2003 and plans to add AI-related objectives in 2025. Its commerce division handles household appliance distribution and digital marketing strategy consulting. Simultaneously, the life care division focuses on developing dementia treatments and central nervous system disease treatments. The company is actively pursuing customer-tailored solutions by expanding Coupang Rocket Delivery, broadening its pipeline, and adopting digital marketing trend technologies.